Trial by market

Article Abstract:

The creation of a single European market has two overriding objectives: to improve the economic competitiveness of European Community members, and to bring them into closer political and economic union. Signs of success in meeting these objectives are already being seen. There has been increased investment by European countries, more mergers and acquisitions, and increased efforts of American, Japanese and other non-members to set up plants and subsidiaries within the EC. A significant portion of the EC's economic growth for 1989 was attributed to the impending creation of the single market. The true measure of success, however, will be the performance of the single market when it graduates to free trade.

International trade

---

Bread before bricks

Article Abstract:

The 'International Management' magazine's survey of the European Community's top 500 companies in 1990 reveals significant differences in the performances of various European business sectors. The food and consumer products sector in 1990 had a healthy 6% average increase in turnover, with profits remaining steady. The retailing and electronics sectors also posted healthy increases in turnover, but with more modest profit growth. On the other hand, the chemicals, motors and construction sectors posted sharp declines in profits as a result of the equally sharp drops in their margins.

Management, Cover Story, Corporations, Corporations, European

---

Drugs companies in a fix

Article Abstract:

European dominance in the pharmaceuticals industry may be deeply affected by the creation of a unified market in Europe. The European Commission's proposed regulatory changes are expected to trigger a long period of consolidation in the industry, with most analysts projecting a decline in the competitive strength of European pharmaceutical companies. The Commission's proposals involve three main issues: the creation of a European Medicines Evaluation Agency by 1993, standardization of rules on drug marketing, and the implementation of a free-trade oriented pricing policy.

Pharmaceutical preparations, Drugs, Laws, regulations and rules, Pharmaceutical industry, Prices and rates, Marketing, European Union. European Commission

Similar abstracts:

• Abstracts: Failtrack. Blood on the tracks. Where's the money coming from?
• Abstracts: Japan tidal wave. European winners. M & A the Japanese way
• Abstracts: Can a market leader regain the initiative when its performance slips?
• Abstracts: Companies that made their mark. Brussels calls for a clean fight
• Abstracts: New kids on the bloc. Sustaining Europe's poorer regions. Feast and famine

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.